Acidic pH-Activated Gas-Generating Nanoparticles with Pullulan Decorating for Hepatoma-Targeted Ultrasound Imaging
Source abstract
Abstract
Contrast-enhanced ultrasound (US) is a widely used imaging modality for hepatocellular carcinoma diagnosis. Mostly, US imaging is confined to the intravascular process because of the limitation of the microbubble contrast agent currently utilized. Targeted contrast agents that incline to accumulate in tumor tissue or tumor cells and enhance the US signal may advance the sensitivity of ultrasonography and exploit the dimension of US imaging of tumor at the molecular level. In this study, we developed CaCO3/pul-PCB (CPP) hybrid nanoparticles with hepatoma-targeting pullulan decorating on the surface through a mineralization route using the pullulan-graft-poly(carboxybetaine methacrylate) (pul-PCB) copolymer as a modifier. This particle was stable in blood physiological pH and generated echogenic CO2 bubbles under tumoral acidic conditions, which enabled the US signal enhancement. Upon intravenous injection, CPP hybrid nanoparticles accumulated efficiently in tumor tissue and exhibited sixfold contrast enhancement in 35 min at the tumor site in the hepatoma-bearing mice model. By contrast, there was barely any signal change in normal liver tissue. Therefore, the presented CPP hybrid nanoparticle is a promising contrast agent for effective US imaging of hepatoma.
Source: openalex_inverted_index · Quality: baseline
Research context
OpenAlex topics: Nanoparticle-Based Drug Delivery · Hepatocellular Carcinoma Treatment and Prognosis · Ultrasound and Hyperthermia Applications
SciVX discovery tags are terminology-based. OpenAlex topics are source-provided classifications.
Affiliations
DSAPM Lab and PCFM Lab, School of Materials Science and Engineering, Sun Yat-sen University, Guangzhou 510275, China
Department of Ultrasound, Sun Yat-sen Memorial Hospital, Sun Yat-sen University, Guangzhou 510120, China
Funding
National Natural Science Foundation of China · National Basic Research Program of China · People's Livelihood and Technology Planning Project of Guangzhou City of China · Applied Science and Technology Research and Development in Guangdong Province
References (44)
Show source-provided references
1. 10.1016/s0140-6736(18)30010-210.1016/s0140-6736(18)30010-2 ↗
2. 10.1136/gut.48.2.25110.1136/gut.48.2.251 ↗
3. 10.1053/j.gastro.2015.12.04110.1053/j.gastro.2015.12.041 ↗
4. 10.1007/s12072-010-9165-710.1007/s12072-010-9165-7 ↗
5. 10.1016/j.jvs.2016.12.13310.1016/j.jvs.2016.12.133 ↗
6. 10.1016/j.ultrasmedbio.2010.01.00410.1016/j.ultrasmedbio.2010.01.004 ↗
7. 10.1259/bjr/1779054710.1259/bjr/17790547 ↗
8. 10.1097/00004424-200011000-0000310.1097/00004424-200011000-00003 ↗
9. 10.1097/00004424-200001000-0000910.1097/00004424-200001000-00009 ↗
10. 10.1007/s00330-004-2298-010.1007/s00330-004-2298-0 ↗
11. 10.2214/ajr.12.1051810.2214/ajr.12.10518 ↗
12. 10.1111/j.1365-2036.2009.04014.x10.1111/j.1365-2036.2009.04014.x ↗
13. 10.1002/hep.2419910.1002/hep.24199 ↗
14. 10.1016/j.jhep.2011.12.00110.1016/j.jhep.2011.12.001 ↗
15. 10.1007/s12072-010-9165-710.1007/s12072-010-9165-7 ↗
16. 10.1159/00031574010.1159/000315740 ↗
17. 10.1016/j.ejrad.2015.03.01610.1016/j.ejrad.2015.03.016 ↗
18. 10.2214/ajr.12.856810.2214/ajr.12.8568 ↗
19. 10.2967/jnumed.109.06800710.2967/jnumed.109.068007 ↗
20. 10.1200/jco.2016.70.859410.1200/jco.2016.70.8594 ↗
21. 10.1097/rli.0b013e3181c5927c10.1097/rli.0b013e3181c5927c ↗
22. 10.1016/j.cbpa.2018.03.01710.1016/j.cbpa.2018.03.017 ↗
23. 10.1021/mp900181610.1021/mp9001816 ↗
24. 10.1016/j.biomaterials.2014.10.01310.1016/j.biomaterials.2014.10.013 ↗
25. 10.1021/nn506210a10.1021/nn506210a ↗
26. 10.1021/acsami.6b0211510.1021/acsami.6b02115 ↗
27. 10.1016/j.jconrel.2015.12.05110.1016/j.jconrel.2015.12.051 ↗
28. 10.1002/adhm.20170095710.1002/adhm.201700957 ↗
29. 10.1016/j.jconrel.2015.02.02210.1016/j.jconrel.2015.02.022 ↗
30. 10.1016/j.jconrel.2007.01.00510.1016/j.jconrel.2007.01.005 ↗
31. 10.1021/am504203x10.1021/am504203x ↗
32. 10.1039/c4tb00321g10.1039/c4tb00321g ↗
33. 10.1016/j.ijpharm.2015.02.02710.1016/j.ijpharm.2015.02.027 ↗
34. 10.1088/1361-6528/aac4b510.1088/1361-6528/aac4b5 ↗
35. 10.1021/la062175d10.1021/la062175d ↗
36. 10.1021/bm060137310.1021/bm0601373 ↗
37. 10.1073/pnas.121055210910.1073/pnas.1210552109 ↗
38. 10.1002/anie.20090357210.1002/anie.200903572 ↗
39. 10.1021/acssuschemeng.5b0038710.1021/acssuschemeng.5b00387 ↗
40. 10.1038/natrevmats.2016.1410.1038/natrevmats.2016.14 ↗
41. 10.1016/0039-9140(96)01925-x10.1016/0039-9140(96)01925-x ↗
42. 10.1021/jp503473u10.1021/jp503473u ↗
43. 10.1021/bm800407r10.1021/bm800407r ↗
44. 10.1021/acs.biomac.5b0155510.1021/acs.biomac.5b01555 ↗